{"id":"https://openalex.org/W2594840960","doi":"https://doi.org/10.1111/bcp.13287","title":"A population pharmacokinetic meta\u2010analysis of custirsen, an antisense oligonucleotide, in oncology patients and healthy subjects","display_name":"A population pharmacokinetic meta\u2010analysis of custirsen, an antisense oligonucleotide, in oncology patients and healthy subjects","publication_year":2017,"publication_date":"2017-03-11","ids":{"openalex":"https://openalex.org/W2594840960","doi":"https://doi.org/10.1111/bcp.13287","mag":"2594840960","pmid":"https://pubmed.ncbi.nlm.nih.gov/28294391","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5555861"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.13287","doi":"https://doi.org/10.1111/bcp.13287","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.13287","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.13287","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.13287","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103571479","display_name":"Alena Y. Z. Edwards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091422","display_name":"Icon (United Kingdom)","ror":"https://ror.org/00cndk772","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091422"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alena Y. Edwards","raw_affiliation_strings":["ICON, Marlow, Buckinghamshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICON, Marlow, Buckinghamshire, UK","institution_ids":["https://openalex.org/I4210091422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049144787","display_name":"Anna Elgart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Anna Elgart","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd., Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd., Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111769584","display_name":"Colm B. Farrell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091422","display_name":"Icon (United Kingdom)","ror":"https://ror.org/00cndk772","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091422"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Colm Farrell","raw_affiliation_strings":["ICON, Marlow, Buckinghamshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICON, Marlow, Buckinghamshire, UK","institution_ids":["https://openalex.org/I4210091422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005524023","display_name":"Ofra Barnett\u2010Griness","orcid":"https://orcid.org/0009-0004-0563-9230","observed_orcids":["https://orcid.org/0009-0004-0563-9230"]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ofra Barnett\u2010Griness","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd., Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd., Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077349491","display_name":"Laura Rabinovich\u2010Guilatt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Rabinovich\u2010Guilatt","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd., Frazer, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd., Frazer, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076108650","display_name":"Ofer Spiegelstein","orcid":"https://orcid.org/0009-0006-1758-1202","observed_orcids":["https://orcid.org/0009-0006-1758-1202"]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ofer Spiegelstein","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd., Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd., Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5049144787"],"corresponding_institution_ids":["https://openalex.org/I4210109720"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.1798,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.78089907,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"83","issue":"9","first_page":"1932","last_page":"1943"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.5151000022888184,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.5151000022888184,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14364","display_name":"Clusterin in disease pathology","score":0.10180000215768814,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.06300000101327896,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ogx-011","display_name":"OGX-011","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9390000104904175},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.8629999756813049},{"id":"https://openalex.org/keywords/clusterin","display_name":"clusterin","score":0.8920000195503235},{"id":"https://openalex.org/keywords/three-compartment-model","display_name":"three-compartment model","score":0.765999972820282},{"id":"https://openalex.org/keywords/nonlinear-mixed-effects-models","display_name":"nonlinear mixed-effects models","score":0.6869999766349792},{"id":"https://openalex.org/keywords/covariate-effects","display_name":"covariate effects","score":0.6119999885559082},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.652999997138977},{"id":"https://openalex.org/keywords/age-and-weight-effects","display_name":"age and weight effects","score":0.671999990940094},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.6990000009536743},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5759999752044678},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4740000069141388},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.7379999756813049},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.45100000500679016},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.36899998784065247},{"id":"https://openalex.org/keywords/first-order-elimination","display_name":"first-order elimination","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6562597751617432},{"id":"https://openalex.org/C3020755252","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Population pharmacokinetics","level":3,"score":0.6164788603782654},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5696163177490234},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5550091862678528},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5057957172393799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47572019696235657},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.4639674425125122},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4254996180534363},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32105553150177},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29332223534584045},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16556650400161743},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07134401798248291},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.06517934799194336}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D017711","descriptor_name":"Nonlinear Dynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/bcp.13287","doi":"https://doi.org/10.1111/bcp.13287","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.13287","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.13287","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5066464","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5555861","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5555861","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5555861","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:28294391","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28294391","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/bcp.13287","doi":"https://doi.org/10.1111/bcp.13287","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.13287","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.13287","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2594840960.pdf","grobid_xml":"https://content.openalex.org/works/W2594840960.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1535918788","https://openalex.org/W1543025719","https://openalex.org/W1562188985","https://openalex.org/W1602607863","https://openalex.org/W1891796305","https://openalex.org/W1996830134","https://openalex.org/W2008154913","https://openalex.org/W2042553471","https://openalex.org/W2063773406","https://openalex.org/W2072423695","https://openalex.org/W2079048469","https://openalex.org/W2080843536","https://openalex.org/W2094269170","https://openalex.org/W2105526550","https://openalex.org/W2108189527","https://openalex.org/W2112507699","https://openalex.org/W2113425358","https://openalex.org/W2117701024","https://openalex.org/W2119581490","https://openalex.org/W2120416054","https://openalex.org/W2151623120","https://openalex.org/W2157668743","https://openalex.org/W2169140729"],"related_works":["https://openalex.org/W2054751725","https://openalex.org/W2595986426","https://openalex.org/W2740359398","https://openalex.org/W2761264264","https://openalex.org/W2891973699","https://openalex.org/W2114806341","https://openalex.org/W4393012018","https://openalex.org/W1543025719","https://openalex.org/W1509522044","https://openalex.org/W2052494733"],"abstract_inverted_index":{"Aims":[0],"Custirsen":[1,139],"(OGX\u2010011/TV\u20101011),":[2],"a":[3,94,145,152,233],"second\u2010generation":[4],"antisense":[5],"oligonucleotide":[6],"that":[7],"reduces":[8],"clusterin":[9],"production,":[10],"is":[11],"under":[12],"investigation":[13],"with":[14,75,128,134,148,156],"chemotherapy":[15],"in":[16,30,59,246,257],"prostate":[17],"and":[18,33,54,111,117,161,225,249],"lung":[19],"cancer.":[20],"This":[21],"meta\u2010analysis":[22],"evaluated":[23],"the":[24,168,203],"population":[25,38,88,238],"pharmacokinetics":[26],"(PK)":[27],"of":[28,67,113,136,185,194,202],"custirsen":[29,42,68,242,258],"cancer":[31,247],"patients":[32,63,248],"healthy":[34,77,250],"subjects.":[35],"Methods":[36],"The":[37,123],"PK":[39,89,140,239],"analysis":[40],"used":[41],"plasma":[43],"concentrations":[44,130],"from":[45,100,131],"five":[46],"Phase":[47,51,56,102,115,119],"1":[48,103,116],"studies,":[49,106],"one":[50,55,118],"1/2":[52,105],"study,":[53],"3":[57,120],"study":[58],"two":[60,114],"stages.":[61],"Cancer":[62],"received":[64,79],"multiple":[65,82],"doses":[66,83,135],"(40\u2013640":[69],"mg":[70,166],"intravenously":[71],"over":[72],"120":[73],"min)":[74],"chemotherapy;":[76],"subjects":[78,133],"single":[80],"or":[81,104],"(320\u2013640":[84],"mg).":[85],"An":[86],"interim":[87],"model":[90,109,125,147,240],"was":[91,126,141,232,243],"developed":[92,127,245],"using":[93],"nonlinear":[95],"mixed\u2010effect":[96],"approach":[97],"incorporating":[98],"data":[99],"four":[101],"followed":[107],"by":[108,144],"refinement":[110],"inclusion":[112],"studies.":[121],"Results":[122],"final":[124],"5588":[129],"631":[132],"160\u2013640":[137],"mg.":[138],"adequately":[142],"described":[143],"three\u2010compartment":[146],"first\u2010order":[149],"elimination.":[150],"For":[151],"representative":[153],"66\u2010year\u2010old":[154],"individual":[155],"body":[157],"weight":[158,224],"82":[159],"kg":[160],"serum":[162,226],"creatinine":[163,227],"level":[164],"0.933":[165],"dl\u22121,":[167],"estimated":[169],"typical":[170],"(95%":[171],"CI)":[172],"parameter":[173],"values":[174],"were":[175,228],"clearance":[176],"(CL)":[177],"=":[178,188,197,208],"2.36":[179],"(2.30\u20132.42)":[180],"l":[181,216,221],"h\u22121,":[182,217],"central":[183],"volume":[184,193,201],"distribution":[186,195],"(V1)":[187],"6.08":[189],"(5.93\u20136.23)":[190],"l,":[191,200,211],"peripheral":[192,205],"(V2)":[196],"1.13":[198],"(1.01\u20131.25)":[199],"second":[204],"compartment":[206],"(V3)":[207],"15.8":[209],"(14.6\u201317.0)":[210],"inter\u2010compartmental":[212],"clearanceQ2=":[213],"0.0755":[214],"(0.0689\u20130.0821)":[215],"andQ3=":[218],"0.0573":[219],"(0.0532\u20130.0614)":[220],"h\u22121.":[222],"Age,":[223],"predictors":[229],"ofCL;":[230],"age":[231],"predictor":[234],"ofQ3.":[235],"Conclusion":[236],"A":[237],"for":[241],"successfully":[244],"subjects,":[251],"including":[252],"covariates":[253],"contributing":[254],"to":[255],"variability":[256],"PK.":[259]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-03-16T00:00:00"}